Can green tea cause liver damage? Yes, but almost entirely through concentrated extracts, not the brewed drink. Standard brewed green tea contains roughly 50–100 mg of catechins per cup and has triggered only a handful of documented liver injuries worldwide. High-dose supplements delivering 500–1,000 mg of EGCG daily are the real culprit, and a small subset of people, perhaps 1 in 1,000 supplement users, develop measurable liver enzyme rises. The injury is dose-dependent, idiosyncratic, and usually reversible after stopping the product. Tea drinking itself remains safe for the overwhelming majority of adults.
The mechanism: EGCG, mitochondria, and oxidative stress
The liver injury from green tea is driven by epigallocatechin gallate, or EGCG, the most abundant catechin in the leaf. At low doses EGCG acts as an antioxidant, which is why the drink is marketed as protective. Above a threshold, the same molecule flips behavior. EGCG undergoes extensive first-pass metabolism in the liver, and in a fraction of people it accumulates faster than glucuronidation and sulfation can clear it.
Once intracellular EGCG concentrations rise, it generates reactive oxygen species and disrupts mitochondrial membrane potential. This is the key step: hepatocytes lose ATP production and begin to leak. In severe cases the injury pattern is hepatocellular, meaning the damage centers on liver cells rather than bile ducts. In plain terms, the supplement overwhelms the liver's ability to detoxify a compound that is harmless at the strength found in a teacup.
The distinguishing feature of tea-related injury is that it mimics acute hepatitis on a blood test, with elevated transaminases, while acetaminophen toxicity typically causes massive centrilobular necrosis at much higher doses. That distinction matters clinically because tea injury is rare and easily missed.
Quantified context: how much EGCG triggers what
The dose-response relationship is the single most useful fact to understand. Roughly 300 mg of EGCG per day, taken on an empty stomach, is enough to produce measurable liver enzyme elevation in sensitive individuals. Supplements often deliver 500 mg to 1,000 mg in a single capsule, which is 5 to 20 times what a heavy tea drinker gets from brewed tea.
| Intake source | Typical EGCG per serving | Daily EGCG at normal use | Liver injury reports |
|---|---|---|---|
| Brewed green tea (1 cup, 8 oz) | 50–80 mg | 50–300 mg | Very rare |
| Matcha (1 tsp, whisked) | 60–120 mg | 60–360 mg | Very rare |
| Standard extract capsule | 250–500 mg | 250–500 mg | Occasional |
| High-dose "fat burner" capsule | 500–1,000 mg | 500–1,000 mg | Most reported cases |
| Multi-capsule supplement stack | 800–1,500 mg | up to 1,500 mg | Concentrated risk |
Per the United States Pharmacopeia's 2016 safety review, EGCG from supplements should not be taken on an empty stomach, and products should be accompanied by food. The European Food Safety Authority in 2018 concluded that 800 mg of EGCG per day from supplements is a level of no concern for most adults, which is considerably higher than a brewed tea diet provides.
Timeline: what happens after a toxic dose
Symptoms from supplement-related tea injury usually don't appear immediately. The delay is part of what makes the condition dangerous, because a person may keep taking the product for weeks while the liver is under stress.
| Time after starting or increasing dose | What is happening | Typical signs |
|---|---|---|
| Days 1–7 | EGCG accumulates; early enzyme leakage begins | Usually none |
| Week 1–3 | Hepatocellular stress builds | Fatigue, nausea, vague malaise |
| Week 2–8 | Transaminases rise sharply | Dark urine, jaundice in some cases |
| Peak injury (often week 3–6) | Acute hepatitis-like pattern | ALT and AST elevated 5–50 times normal |
| Within 1–4 weeks of stopping | Liver regenerates | Enzyme levels fall |
| 1–3 months | Recovery in most cases | Labs normalize |
A 2022 review in the journal LiverTox, maintained by the National Institute of Diabetes and Digestive and Kidney Diseases, describes a latency of roughly 1 to 12 weeks for herbal and botanical injuries, with green tea extract fitting that pattern. The recovery window is usually 1 to 4 weeks once the offending supplement is stopped.
Who is actually at risk: the idiosyncratic edge cases
The most counterintuitive fact about green tea liver injury is that it is not a predictable poisoning. Most people take large EGCG doses without any liver problem. The injury clusters in specific populations with specific vulnerabilities.
People who take supplements on an empty stomach absorb EGCG far faster and achieve higher peak blood levels. Fasting dramatically raises the risk, because food, especially protein and fat, slows absorption and provides competing substrates for metabolism. Anyone on a detox or weight-loss regimen that combines fasting with a "fat-burning" green tea product is compounding two risk factors at once.
Genetic variation in the enzymes that process EGCG, notably UGT1A4 and COMT, appears to explain part of the idiosyncrasy. People with certain polymorphisms clear the catechin slowly. Women also appear to be overrepresented in injury case reports, possibly because of differences in body weight, hormonal regulation of liver enzymes, and supplement use patterns.
Drug interactions matter. Combining high-dose green tea extract with acetaminophen, statins, or other hepatically metabolized drugs can push a marginal liver into injury. Alcohol adds oxidative stress on top of the mitochondrial burden EGCG already imposes.
The practical takeaway: the risk is not evenly distributed, and the groups most likely to use concentrated extracts, dieters and fitness supplement users, are also the ones most likely to take them on an empty stomach.
The "green tea is always healthy" misconception
Brewed green tea has a long safety record, which is real and deserves defense. Population studies from Japan and China, where people drink several cups daily for decades, do not show elevated population-level liver injury. A review of the medical literature up to 2020 finds that documented liver injury from brewed tea alone is vanishingly rare.
The confusion arises because supplements and the drink share a name but not a dose. A cup of tea delivers roughly 50 to 80 mg of EGCG in a large volume of water, sipped over minutes with food. A capsule delivers 500 mg or more at once, often on an empty stomach. That is a 10-fold difference in peak exposure per swallow.
There is also a secondary misconception that green tea protects against liver disease, which has led some people with existing fatty liver or hepatitis to take high-dose extracts as self-treatment. In those patients, an already stressed liver is the last organ that should receive a concentrated catechin dose.
What to actually do: safe use and warning signs
The positive case for green tea remains strong. Drinking 2 to 4 cups daily is associated with modest cardiovascular and metabolic benefits in observational data, and the dose stays well below any risk threshold. If you want the benefits without the risk, choose the drink over the pill.
If you take a green tea extract, follow the product label and never exceed the stated dose. Take it with a meal, never on an empty stomach. Avoid combining it with alcohol, acetaminophen, or other supplements that stress the liver. Stop immediately if any of the following appear:
- Dark urine, like cola or tea, that is not explained by diet or hydration
- Yellowing of the eyes or skin, or pale stools
- Persistent nausea, vomiting, or pain in the upper right abdomen
- Unexplained fatigue lasting more than a few days
- New itching without a rash
- Any of these symptoms while taking a green tea supplement
If you have known liver disease, are pregnant, or take prescription medications, talk to a clinician before starting any concentrated botanical extract. And if you choose to take one, ask your provider whether a baseline liver panel makes sense given your history.
Limitations and what the evidence cannot yet tell us
The evidence base for green tea liver injury is built almost entirely on case reports and voluntary adverse event registries. Those sources are excellent at flagging signals but poor at estimating true incidence. We do not have randomized trials that dose healthy people with EGCG to measure liver enzyme changes over months, and we likely never will, because such a trial would be ethically fraught.
The exact incidence is therefore unknown. Estimates from adverse event reporting range widely, from under 1 in 10,000 to around 1 in 1,000 supplement users, and the wide band reflects underreporting and inconsistent diagnostic criteria. Many people with mild enzyme elevations never get tested and never report.
Diagnosis is also confounded. Herbal supplement labels often list proprietary blends that understate actual EGCG content, and consumers may take multiple products at once. Attributing liver injury to green tea alone in a real patient is harder than it sounds.
What is established: high-dose EGCG supplements can injure the liver through mitochondrial oxidative stress, the injury is usually reversible after stopping, and brewed tea at ordinary intake has not shown this pattern. What remains uncertain: the precise safe upper limit for every population, the role of genetic variants, and whether long-term low-dose supplementation carries any risk below the thresholds now discussed. Until better data exist, the reasonable position is that the drink is safe, the high-dose pill demands respect, and symptoms deserve prompt medical attention rather than a wait-and-see approach.